Bloodstream adiponectin levels are higher in patients with chronic kidney disease (CKD), and elevated levels of adiponectin predict increased cardiovascular and all-cause mortality and CKD progression [131]. This evidence concerns the gene ADIPOQ and chronic kidney disease.